AI-designed drug appears to turn back the body's biological clock in early trial

The DecoderSeptember 7, 2026en

A study in Nature Biotechnology suggests that rentosertib, a drug designed with AI by Insilico Medicine, may reverse markers of biological aging. Six independent aging clocks predicted that treated patients were biologically up to six years younger than the placebo group. The trial covered just 42 patients and the drug hasn't been tested in healthy people yet. The article AI-designed drug appears to turn back the body's biological clock in early trial appeared first on The Decoder .

This is a short summary published by AI Global Wire. The full article is owned and hosted by The Decoder — open it there to read it in full.

• Verktyg
• Forskning